Product: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC  73702-203-65.
Reason for recall: cGMP deviations.
Recall initiated: 20260401
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated